DOCSLIB.ORG

Activation of the NF-Kb Pathway by Caspase 8 and Its Homologs

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Activation of the NF-Kb Pathway by Caspase 8 and Its Homologs Oncogene (2000) 19, 4451 ± 4460 ã 2000 Macmillan Publishers Ltd All rights reserved 0950 ± 9232/00 $15.00 www.nature.com/onc Activation of the NF-kB pathway by Caspase 8 and its homologs Preet M Chaudhary*,1, Michael T Eby1, Alan Jasmin1, Arvind Kumar1, Li Liu1 and Leroy Hood2 1Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas, TX 75390-8593, USA; 2Department of Molecular Biotechnology, University of Washington, Seattle, Washington, WA 98195 USA Caspase 8 is the most proximal caspase in the caspase al., 1996). The prodomain of Caspase 8 consists of two cascade and has been known for its role in the mediation homologous DEDs and serves to keep Caspase 8 in an of cell death by various death receptors belonging to the inactive form (Chinnaiyan and Dixit, 1997). DEDs- TNFR family. We have discovered that Caspase 8 can containing prodomains are also found in two addi- activate the NF-kB pathway independent of its activity tional cellular proteins; Caspase 10 (Mch4, FLICE2), a as a pro-apoptotic protease. This property is localized to proteolytically active Caspase 8 homolog (Fernandes- its N-terminal prodomain, which contains two homo- Alnemri et al., 1996; Vincenz and Dixit, 1997), and logous death eector domains (DEDs). Caspase 10 and MRIT (Casper, c-FLIP, I-FLICE, FLAME, CASH, MRIT, two DEDs-containing homologs of Caspase 8, CLARP), a Caspase 8 homolog which is devoid of can similarly activate the NF-kB pathway. Dominant- protease activity (Goltsev et al., 1997; Han et al., 1997; negative mutants of the Caspase 8 prodomain can block Hu et al., 1997; Inohara et al., 1997; Irmler et al., 1997; NF-kB induced by Caspase 8, FADD and several death Shu et al., 1997; Srinivasula et al., 1997). receptors belonging to the TNFR family. Caspase 8 can In the present study present evidence that the DEDs interact with multiple proteins known to be involved in of Caspase 8 and its homologs are also involved in the the activation of the NF-kB pathway, including the activation of the NF-kB pathway. Our study suggests serine-threonine kinases RIP, NIK, IKK1 and IKK2. the existence of a functional and biochemical link Thus, DEDs-containing caspases and caspase homolog(s) between the caspase and the kinase cascades down- may have functions beyond their known role in the stream of the adaptor molecule TRADD and indicates mediation of cell death. Oncogene (2000) 19, 4451 ± that Caspase 8 and its homologs have roles beyond 4460. their activity as cell death proteases. Keywords: NF-kB; caspase; FADD; death eector domain; MRIT; cFLIP Results Caspase 8 activates NF-kB Introduction We began by testing the ability of Caspase 8 to activate Tumor Necrosis Factor Receptor 1 (TNFR1) is the an NF-kB-driven luciferase reporter construct in 293T best characterized death receptor of the TNFR family cells (Berberich et al., 1994). Expression of Caspase 8 in (Ashkenazi and Dixit, 1998; Baker and Reddy, 1996). these cells had no major toxicity and led to signi®cant On ligand induced aggregation, death domain of activation of the NF-kB/luciferase reporter construct in TNFR1 binds the homologous domain of TRADD, a a dose- and time-dependent manner (Figure 1a ± c). death domain-containing cytoplasmic adaptor protein Caspase 8 failed to activate luciferase reporter constructs (Hsu et al., 1995, 1996; Varfolomeev et al., 1996). driven by mutant NF-kB binding-sites, NF-IL6 or TRADD subsequently activates a kinase cascade, NFAT, which demonstrated the speci®city of the assay consisting of the NF-kB and JNK/SAPK pathways, (Figure 1a and data not shown). The NF-kB inducing via the recruitment of death domain-containing protein ability of Caspase 8 was not limited to the 293T cells RIP (Receptor Interacting Protein) and TRAF2, which since it activated NF-kB in the MCF7 and 293 EBNA lacks a death domain (TNF Receptor Associated cells as well (Figure 1d and data not shown). The ability Factor 1). TRADD also activates a caspase cascade of Caspase 8 to activate the NF-kB pathway was further via the recruitment of FADD/MORT1, another con®rmed by an electrophoretic mobility shift assay, adaptor protein, which possesses a C-terminal death which also con®rmed the speci®city of this response domain and an N-terminal `death eector domain' (Figure 1e). However, Caspase 8 was a relatively weaker (Boldin et al., 1995; Chinnaiyan et al., 1995, 1996; Hsu stimulator of the NF-kB pathway as compared to et al., 1996; Varfolomeev et al., 1996). The DED of TNFR1 (Figure 1e). FADD binds to the N-terminal prodomain of Caspase 8 (also called FLICE, MACH or Mch5), a pro- The prodomain of Caspase 8 mediates NF-kB activation apoptotic apical caspase of the caspase cascade (Boldin et al., 1996; Fernandes-Alnemri et al., 1996; Muzio et The observed ability of Caspase 8 to activate the NF- kB pathway could be secondary to its ability to activate the cell death pathway and the resultant activation of stress-response genes. To separate the *Correspondence: PM Chaudhary, Hamon Center for Therapeutic NF-kB inducing ability of Caspase 8 from its ability to Oncology Research, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas, TX 75390-8593, USA act as a pro-apoptotic caspase, we tested the ability of Received 22 May 2000; revised 30 May 2000; accepted 19 July various deletion and point mutants of Caspase 8 to 2000 activate the NF-kB pathway. Activation of NF-kB by caspases PM Chaudhary et al 4452 Figure 1 Caspase 8 induces NF-kB. (a) 293T cells were transfected with a Caspase 8 expression vector (750 ng) or an empty vector (750 ng) along with an NF-kB/luciferase reporter construct (75 ng) as well as a RSV/LacZ (b-gal) reporter construct (75 ng) in duplicate and reporter assay for NF-kB activation performed as described in the Materials and methods section. A control experiment was performed with a mutant NF-kB/luciferase reporter construct in parallel. The values shown are averages (mean+s.e.m.) of one representative experiment out of three in which each transfection was performed in duplicate. (b) Dose- response of Caspase 8-induced NF-kB activation. 293T cells were transfected with empty vector or indicated amounts (in ng/well) of expression vector for Flag-Caspase 8 C360S in duplicate in each well of a 24-well plate. Western blot analysis with a Flag antibody demonstrates the expression of Caspase 8 at each dose level (right panel). (c) Time course of Caspase 8-induced NF-kB activation. 293T cells were transfected with empty vector or Caspase 8 C360S expression plasmid (250 ng/well) and cell extracts prepared for the measurement of luciferase activity at the indicated time points. (d) Induction of NF-kB by Caspase 8 in the MCF7 cells. MCF7 cells (16105) were transfected with a Caspase 8 expression construct or an empty vector (750 ng each) along with an NF-kB/ luciferase reporter construct (75 ng) in duplicate. Luciferase activity was measured 20 h later. (e) Electrophoretic mobility shift assay. 293T cells were (36105) were transfected with 5 mg of an empty vector (lane 1) or an expression vector encoding the Caspase 8 (lane 2 ± 4) or TNFR1 (lane 5). After 16 h, nuclear extracts were prepared essentially as described previously (Yeh et al., 1997). Nuclear extracts (2 mg) were incubated for 30 min at room temperature with a 32P-labeled NF-kB duplex oligonucleotide (Promega, Madison, WI, USA) in a buer containing 10 mM HEPES (pH 7.9); 50 mM KCl, 0.2 mM EDTA, 2.5 mM DTT, 2 mg poly (dC:dI), 10% glycerol and 0.5% NP-40. Competition was carried out with 100-fold excess of cold NF-kB oligo duplex or a non-speci®c oligo duplex. Protein-DNA complexes were resolved on a 5% native polyacrylamide and run in Tris-glycine buer. Gel was dried and autoradiographed. The position of the induced NF-kB complex is marked by an arrow while * marks the position of a constitutive NF-kB complex. Descriptions of various lanes are as follows: lane 1, empty vector, lane 2, Caspase 8; lane 3, Caspase 8 plus cold non-speci®c competitor duplex; lane 4, Caspase 8 plus cold NF-kB duplex; lane 5, TNFR1 A construct encoding the full-length prodomain of the catalytically active site and is, therefore, proteoly- Caspase 8, containing its two Death Eector Domains tically inactive, was as eective as the wild-type (DEDs) (amino acids 1 ± 180), was able to activate NF- Caspase 8 in activating the NF-kB pathway (Figure 2). kB to an even greater extent than the full-length Caspase 8, whereas deletion constructs encoding either Ability of other caspases to activate NF-kB DED1 (aa 1 ± 103) or DED2 (aa 104 ± 180) alone failed to do so (Figure 2). Similarly, constructs encoding the We also tested the ability of several other caspase full-length protease (caspase homology) domain or the family members to activate the NF-kB pathway. individual p20 or p10 sub-domains failed to activate Unlike Caspase 8, over-expression of Caspase 10 NF-kB (Figure 2 and data not shown). Caspase 8 (Mch4 isoform) led to massive apoptosis in 293T cells C360S, which contains a cysteine to serine mutation at but failed to induce NF-kB (Figure 3a and data not Oncogene Activation of NF-kB by caspases PM Chaudhary et al 4453 the protease activity of both proximal and distal caspases. Both CrmA and p35 were ineective in blocking NF-kB activation by Caspases 8 or 10, thus con®rming that NF-kB activation by these caspases is independent of their ability to activate the caspase cascade (Figure 3d).
Load more

Recommended publications
  • Accumulation of P53 and Reductions in XIAP Abundance Promote the Apoptosis of Prostate Cancer Cells
    Research Article Accumulation of p53 and Reductions in XIAP Abundance Promote the Apoptosis of Prostate Cancer Cells Subhra Mohapatra, Baoky Chu, Xiuhua Zhao, and W.J. Pledger Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida Abstract activates caspase-9. Most drugs signal apoptosis through the Toward the goal of developing effective treatments for mitochondrial pathway. prostate cancers, we examined the effects of cyclin-dependent Proteins that modulate caspase activity and thus determine kinase inhibitors on the survival of prostate cancer cells. We whether cells live or die include the inhibitor of apoptosis proteins show that roscovitine, R-roscovitine, and CGP74514A (collec- (IAPs) and the Bcl-2 proteins. The IAP family includes cIAP-1, cIAP- tively referred to as CKIs) induce the apoptosis of LNCaP and 2, XIAP, and survivin (11). Of these proteins, XIAP is the most potent. LNCaP-Rf cells, both of which express wild-type p53. Apoptosis IAPs interact with and inhibit the activity of processed caspases; required caspase-9 and caspase-3 activity, and cytochrome c thus, they function as ‘‘brakes’’ that can impede the apoptotic accumulated in the cytosol of CKI-treated cells. Amounts of process once it begins. IAPs inactivate both initiator and effector caspases; caspase-9 and caspase-3 are IAP targets, whereas caspase- p53 increased substantially in CKI-treated cells, whereas amounts of the endogenous caspase inhibitor XIAP decreased. 8 is not (12). CKIs did not appreciably induce the apoptosis of LNCaP cells The Bcl-2 proteins are critical determinants of mitochondria- treated with pifithrin-A, which prevents p53 accumulation, or dependent caspase activation (13).
    [Show full text]
  • Life, Death, and the Pursuit of Apoptosis
    Downloaded from genesdev.cshlp.org on October 4, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Life, death, and the pursuit of apoptosis Eileen White Center for Advanced Biotechnology and Medicine and Department of Biological Sciences and the Cancer Institute of New Jersey, Rutgers University, Piscataway, New Jersey 08854 USA Apoptosis or programmed cell death is a genetically con- (Oltvai et al. 1993). Bcl-2 is expressed widely during em- trolled response for cells to commit suicide. The symp- bryogenesis (LeBrun et al. 1993; Novack and Korsmeyer toms of apoptosis are viability loss accompanied by cy- 1994), and its expression becomes more restricted in toplasmic boiling, chromatin condensation, and DNA adult tissues to those requiring long-term survival (stem fragmentation (Wyllie 1980). Pathologists and develop- cells, postmitotic neurons, and proliferating zones; mental biologists have cataloged the occurrences of ap- Hockenbery et al. 1991). optosis for many years based on these defined morpho- Apoptosis plays a major role in normal development, logical features, but what has propelled apoptosis into and it was expected that gain- or loss-of-function of a the forefront of basic research has been the identification death inhibitor such as Bcl-2 would have a phenotype in of genes that control cell death and the appreciation of transgenic mice. Bcl-2 was expected to regulate apopto- the role of apoptosis in development and disease. Regu- sis in lymphoid cells because of the role of Bcl-2 in hu- lation of cell death is essential for normal development man B cell lymphoma. Targeted Bcl-2 overexpression to and is an important defense against viral infection and the lymphoid system extends normal B cell survival the emergence of cancer.
    [Show full text]
  • Apoptotic Threshold Is Lowered by P53 Transactivation of Caspase-6
    Apoptotic threshold is lowered by p53 transactivation of caspase-6 Timothy K. MacLachlan*† and Wafik S. El-Deiry*‡§¶ʈ** *Laboratory of Molecular Oncology and Cell Cycle Regulation, Howard Hughes Medical Institute, and Departments of ‡Medicine, §Genetics, ¶Pharmacology, and ࿣Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 Communicated by Britton Chance, University of Pennsylvania School of Medicine, Philadelphia, PA, April 23, 2002 (received for review January 11, 2002) Little is known about how a cell’s apoptotic threshold is controlled Inhibition of the enzyme reduces the sensitivity conferred by after exposure to chemotherapy, although the p53 tumor suppres- overexpression of p53. These results identify a pathway by which sor has been implicated. We identified executioner caspase-6 as a p53 is able to accelerate the apoptosis cascade by loading the cell transcriptional target of p53. The mechanism involves DNA binding with cell death proteases so that when an apoptotic signal is by p53 to the third intron of the caspase-6 gene and transactiva- received, programmed cell death occurs rapidly. tion. A p53-dependent increase in procaspase-6 protein level al- lows for an increase in caspase-6 activity and caspase-6-specific Materials and Methods Lamin A cleavage in response to Adriamycin exposure. Specific Western Blotting and Antibodies. Immunoblotting was carried out by inhibition of caspase-6 blocks cell death in a manner that correlates using mouse anti-human p53 monoclonal (PAb1801; Oncogene), with caspase-6 mRNA induction by p53 and enhances long-term rabbit anti-human caspase-3 (Cell Signaling, Beverly, MA), mouse survival in response to a p53-mediated apoptotic signal.
    [Show full text]
  • XIAP's Profile in Human Cancer
    biomolecules Review XIAP’s Profile in Human Cancer Huailu Tu and Max Costa * Department of Environmental Medicine, Grossman School of Medicine, New York University, New York, NY 10010, USA; [email protected] * Correspondence: [email protected] Received: 16 September 2020; Accepted: 25 October 2020; Published: 29 October 2020 Abstract: XIAP, the X-linked inhibitor of apoptosis protein, regulates cell death signaling pathways through binding and inhibiting caspases. Mounting experimental research associated with XIAP has shown it to be a master regulator of cell death not only in apoptosis, but also in autophagy and necroptosis. As a vital decider on cell survival, XIAP is involved in the regulation of cancer initiation, promotion and progression. XIAP up-regulation occurs in many human diseases, resulting in a series of undesired effects such as raising the cellular tolerance to genetic lesions, inflammation and cytotoxicity. Hence, anti-tumor drugs targeting XIAP have become an important focus for cancer therapy research. RNA–XIAP interaction is a focus, which has enriched the general profile of XIAP regulation in human cancer. In this review, the basic functions of XIAP, its regulatory role in cancer, anti-XIAP drugs and recent findings about RNA–XIAP interactions are discussed. Keywords: XIAP; apoptosis; cancer; therapeutics; non-coding RNA 1. Introduction X-linked inhibitor of apoptosis protein (XIAP), also known as inhibitor of apoptosis protein 3 (IAP3), baculoviral IAP repeat-containing protein 4 (BIRC4), and human IAPs like protein (hILP), belongs to IAP family which was discovered in insect baculovirus [1]. Eight different IAPs have been isolated from human tissues: NAIP (BIRC1), BIRC2 (cIAP1), BIRC3 (cIAP2), XIAP (BIRC4), BIRC5 (survivin), BIRC6 (apollon), BIRC7 (livin) and BIRC8 [2].
    [Show full text]
  • Expression of the Tumor Necrosis Factor Receptor-Associated Factors
    Expression of the Tumor Necrosis Factor Receptor- Associated Factors (TRAFs) 1 and 2 is a Characteristic Feature of Hodgkin and Reed-Sternberg Cells Keith F. Izban, M.D., Melek Ergin, M.D, Robert L. Martinez, B.A., HT(ASCP), Serhan Alkan, M.D. Department of Pathology, Loyola University Medical Center, Maywood, Illinois the HD cell lines. Although KMH2 showed weak Tumor necrosis factor receptor–associated factors expression, the remaining HD cell lines also lacked (TRAFs) are a recently established group of proteins TRAF5 protein. These data demonstrate that consti- involved in the intracellular signal transduction of tutive expression of TRAF1 and TRAF2 is a charac- several members of the tumor necrosis factor recep- teristic feature of HRS cells from both patient and tor (TNFR) superfamily. Recently, specific members cell line specimens. Furthermore, with the excep- of the TRAF family have been implicated in promot- tion of TRAF1 expression, HRS cells from the three ing cell survival as well as activation of the tran- HD cell lines showed similar TRAF protein expres- ␬ scription factor NF- B. We investigated the consti- sion patterns. Overall, these findings demonstrate tutive expression of TRAF1 and TRAF2 in Hodgkin the expression of several TRAF proteins in HD. Sig- and Reed–Sternberg (HRS) cells from archived nificantly, the altered regulation of selective TRAF paraffin-embedded tissues obtained from 21 pa- proteins may reflect HRS cell response to stimula- tients diagnosed with classical Hodgkin’s disease tion from the microenvironment and potentially (HD). In a selective portion of cases, examination of contribute both to apoptosis resistance and cell HRS cells for Epstein-Barr virus (EBV)–encoded maintenance of HRS cells.
    [Show full text]
  • Supplementary Table 2 Supplementary Table 1
    Supplementary table 1 Rai/ Binet IGHV Cytogenetic Relative viability Fludarabine- Sex Outcome CD38 (%) IGHV gene ZAP70 (%) Treatment (s) Stage identity (%) abnormalities* increase refractory 1 M 0/A Progressive 14,90 IGHV3-64*05 99,65 28,20 Del17p 18.0% 62,58322819 FCR n.a. 2 F 0/A Progressive 78,77 IGHV3-48*03 100,00 51,90 Del17p 24.8% 77,88052021 FCR n.a. 3 M 0/A Progressive 29,81 IGHV4-b*01 100,00 9,10 Del17p 12.0% 36,48 Len, Chl n.a. 4 M 1/A Stable 97,04 IGHV3-21*01 97,22 18,11 Normal 85,4191657 n.a. n.a. Chl+O, PCR, 5 F 0/A Progressive 87,00 IGHV4-39*07 100,00 43,20 Del13q 68.3% 35,23314039 n.a. HDMP+R 6 M 0/A Progressive 1,81 IGHV3-43*01 100,00 20,90 Del13q 77.7% 57,52490626 Chl n.a. Chl, FR, R-CHOP, 7 M 0/A Progressive 97,80 IGHV1-3*01 100,00 9,80 Del17p 88.5% 48,57389901 n.a. HDMP+R 8 F 2/B Progressive 69,07 IGHV5-a*03 100,00 16,50 Del17p 77.2% 107,9656878 FCR, BA No R-CHOP, FCR, 9 M 1/A Progressive 2,13 IGHV3-23*01 97,22 29,80 Del11q 16.3% 134,5866919 Yes Flavopiridol, BA 10 M 2/A Progressive 0,36 IGHV3-30*02 92,01 0,38 Del13q 81.9% 78,91844953 Unknown n.a. 11 M 2/B Progressive 15,17 IGHV3-20*01 100,00 13,20 Del11q 95.3% 75,52880995 FCR, R-CHOP, BR No 12 M 0/A Stable 0,14 IGHV3-30*02 90,62 7,40 Del13q 13.0% 13,0939004 n.a.
    [Show full text]
  • Beyond Tumor Necrosis Factor Receptor: TRADD Signaling in Toll-Like Receptors
    Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors Nien-Jung Chen*†‡, Iok In Christine Chio*‡, Wen-Jye Lin*, Gordon Duncan*, Hien Chau*§, David Katz*¶, Huey-Lan Huang*ʈ, Kelly A. Pike*,**, Zhenyue Hao*, Yu-Wen Su*, Kazuo Yamamoto*, Rene´ e F. de Pooter††, Juan Carlos Zu´ n˜ iga-Pflu¨ cker††, Andrew Wakeham*, Wen-Chen Yeh*, and Tak W. Mak*‡‡ *The Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5G 2C1; †Institute of Microbiology and Immunology, School of Life Science, National Yang-Ming University, Taipei, Taiwan 112, Republic of China; and ††Department of Immunology, University of Toronto, Sunnybrook and Women’s College Health Sciences Centre, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5 Contributed by Tak W. Mak, July 9, 2008 (sent for review June 24, 2008) Tumor necrosis factor receptor 1-associated death domain protein tory responses in vivo, but also that this molecule is involved in (TRADD) is the core adaptor recruited to TNF receptor 1 (TNFR1) germinal center (GC) formation, T cell costimulation, and TLR upon TNF␣ stimulation. In cells from TRADD-deficient mice, TNF␣- signaling. Our TRADD knockout mice represent a very useful mediated apoptosis and TNF␣-stimulated NF-␬B, JNK, and ERK tool for extending the ever-increasing list of TRADD functions activation are defective. TRADD is also important for germinal in vitro and in vivo. center formation, DR3-mediated costimulation of T cells, and TNF␣- mediated inflammatory responses in vivo. TRADD deficiency does Results not enhance IFN␥-induced signaling.
    [Show full text]
  • P53 and the Cathepsin Proteases As Co-Regulators of Cancer and Apoptosis
    cancers Review Making Connections: p53 and the Cathepsin Proteases as Co-Regulators of Cancer and Apoptosis Surinder M. Soond 1,*, Lyudmila V. Savvateeva 1, Vladimir A. Makarov 1, Neonila V. Gorokhovets 1, Paul A. Townsend 2 and Andrey A. Zamyatnin, Jr. 1,3,4,* 1 Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, 119991 Moscow, Russia; [email protected] (L.V.S.); [email protected] (V.A.M.); gorokhovets_n_v@staff.sechenov.ru (N.V.G.) 2 Division of Cancer Sciences and Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, and the NIHR Manchester Biomedical Research Centre, Manchester M13 9PL, UK; [email protected] 3 Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia 4 Department of Biotechnology, Sirius University of Science and Technology, 1 Olympic Ave, 354340 Sochi, Russia * Correspondence: [email protected] (S.M.S.); [email protected] (A.A.Z.J.) Received: 6 October 2020; Accepted: 19 November 2020; Published: 22 November 2020 Simple Summary: This article describes an emerging area of significant interest in cancer and cell death and the relationships shared by these through the p53 and cathepsin proteins. While it has been demonstrated that the p53 protein can directly induce the leakage of cathepsin proteases from the lysosome, directly triggering cell death, little is known about what factors set the threshold at which the lysosome can become permeabilized. It appears that the expression levels of cathepsin proteases may be central to this process, with some of them being transcriptionally regulated by p53.
    [Show full text]
  • The Role of Caspase-2 in Regulating Cell Fate
    cells Review The Role of Caspase-2 in Regulating Cell Fate Vasanthy Vigneswara and Zubair Ahmed * Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK; [email protected] * Correspondence: [email protected] Received: 15 April 2020; Accepted: 12 May 2020; Published: 19 May 2020 Abstract: Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family and has been implicated in both apoptotic and non-apoptotic signaling pathways, including tumor suppression, cell cycle regulation, and DNA repair. A myriad of signaling molecules is associated with the tight regulation of caspase-2 to mediate multiple cellular processes far beyond apoptotic cell death. This review provides a comprehensive overview of the literature pertaining to possible sophisticated molecular mechanisms underlying the multifaceted process of caspase-2 activation and to highlight its interplay between factors that promote or suppress apoptosis in a complicated regulatory network that determines the fate of a cell from its birth and throughout its life. Keywords: caspase-2; procaspase; apoptosis; splice variants; activation; intrinsic; extrinsic; neurons 1. Introduction Apoptosis, or programmed cell death (PCD), plays a pivotal role during embryonic development through to adulthood in multi-cellular organisms to eliminate excessive and potentially compromised cells under physiological conditions to maintain cellular homeostasis [1]. However, dysregulation of the apoptotic signaling pathway is implicated in a variety of pathological conditions. For example, excessive apoptosis can lead to neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, whilst insufficient apoptosis results in cancer and autoimmune disorders [2,3]. Apoptosis is mediated by two well-known classical signaling pathways, namely the extrinsic or death receptor-dependent pathway and the intrinsic or mitochondria-dependent pathway.
    [Show full text]
  • Proteases to Die For
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Proteases to die for Vincent Cryns1 and Junying Yuan2,3 1Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University School of Medicine, Chicago, Illinois 60611 USA; 2Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115 USA Apoptosis or programmed cell death (PCD) is a geneti- have identified two genes (ced-3 and ced-4) that are each cally regulated, cellular suicide mechanism that plays a required for the execution of cell death and one (ced-9) crucial role in development and in the defense of homeo- that inhibits cell death (Hengartner et al. 1992; Yuan and stasis. Cells respond to a variety of disparate signals by Horvitz 1992; Yuan et al. 1993). Mutational analyses of committing suicide through a series of dramatic but re- these genes in C. elegans have defined a sequential cell markably uniform events. Morphologically, cells under- death pathway. Inactivating mutations of ced-9 result in going apoptosis demonstrate nuclear/cytoplasmic con- inappropriate cell deaths, but only if both ced-3 and densation and membrane protrusions. These initial ced-4 are functional (Hengartner et al. 1992). Targeted changes are followed by fragmentation of the nuclear overexpression of either ced-4 or ced-3 induces cell contents and subsequent encapsulation of these frag- death, these cell deaths are inhibited by ced-9. In trans- ments into ‘‘apoptotic bodies’’ that are quickly and un- genic worms, maximal cell death induced by ced-4 over- obtrusively consumed by adjacent cells, thereby leaving expression requires ced-3, whereas ced-3-mediated cell little trace of the apoptotic cell’s prior existence (Kerr et death is independent of ced-4.
    [Show full text]
  • Bax Transmembrane Domain Interacts with Prosurvival Bcl-2 Proteins in Biological Membranes
    Bax transmembrane domain interacts with prosurvival Bcl-2 proteins in biological membranes Vicente Andreu-Fernándeza,b,c, Mónica Sanchoa, Ainhoa Genovésa, Estefanía Lucendoa, Franziska Todtb, Joachim Lauterwasserb,d, Kathrin Funkb,d, Günther Jahreise, Enrique Pérez-Payáa,f,1, Ismael Mingarroc,2, Frank Edlichb,g,2, and Mar Orzáeza,2 aLaboratory of Peptide and Protein Chemistry, Centro de Investigación Príncipe Felipe, E-46012 Valencia, Spain; bInstitute for Biochemistry and Molecular Biology, University of Freiburg, 79104 Freiburg, Germany; cDepartament de Bioquímica i Biologia Molecular, Estructura de Recerca Interdisciplinar en Biotecnología i Biomedicina, Universitat de València, 46100 Burjassot, Spain; dFaculty of Biology, University of Freiburg, 79104 Freiburg, Germany; eDepartment of Biochemistry/Biotechnology, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany; fInstituto de Biomedicina de Valencia, Instituto de Biomedicina de Valencia–Consejo Superior de Investigaciones Científicas, 46010 Valencia, Spain; and gBIOSS, Centre for Biological Signaling Studies, University of Freiburg, 79104 Freiburg, Germany Edited by William F. DeGrado, School of Pharmacy, University of California, San Francisco, CA, and approved November 29, 2016 (received for review July 28, 2016) The Bcl-2 (B-cell lymphoma 2) protein Bax (Bcl-2 associated X, across bilayers via changes in the oligomeric state or protein con- apoptosis regulator) can commit cells to apoptosis via outer mito- formation (22–24). The Bax TMD targets fusion proteins to the chondrial membrane permeabilization. Bax activity is controlled in OMM; its deletion results in cytosolic Bax localization and impaired healthy cells by prosurvival Bcl-2 proteins. C-terminal Bax trans- Bax activity (25). Analysis of the active Bax membrane topology membrane domain interactions were implicated recently in Bax pore suggests that the TMD could play a central role in Bax oligomeri- formation.
    [Show full text]
  • The Molecular Links Between Cell Death and Inflammasome
    cells Review The Molecular Links between Cell Death and Inflammasome Kwang-Ho Lee 1,2 and Tae-Bong Kang 1,2,* 1 Department of Biotechnology, College of Biomedical & Health Science, Konkuk University, Chungju 27478, Korea 2 Research Institute of Inflammatory Diseases, Konkuk University, Chungju 27478, Korea * Correspondence: [email protected]; Tel.: +82-43-840-3904; Fax: +82-43-852-3616 Received: 30 July 2019; Accepted: 9 September 2019; Published: 10 September 2019 Abstract: Programmed cell death pathways and inflammasome activation pathways can be genetically and functionally separated. Inflammasomes are specialized protein complexes that process pro-inflammatory cytokines, interleukin-1β (IL-1β), and IL-18 to bioactive forms for protection from a wide range of pathogens, as well as environmental and host-derived danger molecules. Programmed cell death has been extensively studied, and its role in the development, homeostasis, and control of infection and danger is widely appreciated. Apoptosis and the recently recognized necroptosis are the best-characterized forms of programmed death, and the interplay between them through death receptor signaling is also being studied. Moreover, growing evidence suggests that many of the signaling molecules known to regulate programmed cell death can also modulate inflammasome activation in a cell-intrinsic manner. Therefore, in this review, we will discuss the current knowledge concerning the role of the signaling molecules originally associated with programmed cell death in the activation of inflammasome and IL-1β processing. Keywords: inflammasome; apoptosis; necroptosis; programmed cell death; Caspase-8; RIPK1/3; MLKL; PGAM5; DRP1 1. Introduction Homeostasis is a principle property of living organisms and it is maintained at the systemic, tissue, and cellular levels through the homeostatic control system.
    [Show full text]